When appetite suppression starts with semaglutide — and what to expect first

The myth worth correcting: full appetite suppression does not arrive on day one

A very common expectation is that Wegovy will switch off hunger almost immediately after the first injection. That is understandable, the marketing language around GLP-1 medicines can make them sound instant. The reality is more gradual, and knowing that upfront saves a lot of frustration.

Semaglutide starts activating GLP-1 receptors from the first dose, and some people do notice a subtle change in the first week, food feels less urgent, portion sizes feel easier to manage. But 0.25 mg is a tolerability dose. Its job is to let your digestive system adjust quietly rather than to produce strong hunger reduction. Expecting the meal-skipping effect that some people describe at 2.4 mg to appear at 0.25 mg sets you up for disappointment.

The appetite-suppressing effect described in the STEP 1 trial (published in the New England Journal of Medicine), where participants on semaglutide 2.4 mg lost an average of around 15% of body weight over 68 weeks, was built over months of titration, not days. The signal builds. That is not a flaw in the medicine; it is how the mechanism works safely.

If you are in week two feeling roughly the same hunger levels as before, that is normal. Give it time, and give the dose room to rise.

When most people begin noticing a real change in appetite

If you are wondering more specifically when semaglutide begins suppressing appetite in a practical sense, the pattern that emerges from clinical experience is broadly this: some softening of appetite in weeks one to four at 0.25 mg; a more noticeable shift after the step to 0.5 mg or 1.0 mg, typically between weeks four and twelve; and for many people, the clearest effect at 1.7 mg or 2.4 mg, which arrives several months into treatment.

This is not universal. A minority of people feel quite a strong effect early. Others reach 1.0 mg and still feel little change, then find 1.7 mg is the level that shifts things. Metabolism, body composition, gut transit speed and individual GLP-1 receptor sensitivity all vary. Semaglutide is not a uniform experience.

The NHS medicines page for semaglutide notes that the most common side effects (nausea, reduced appetite, and digestive changes) are most pronounced at the start of treatment and after each dose increase, then tend to settle. This is a useful frame: the dose-increase moments are often when appetite changes are most noticeable, positively and in terms of side effects alike.

It is also worth understanding that appetite suppression is not the only mechanism at work. Semaglutide slows gastric emptying, so food stays in the stomach longer, extending the feeling of fullness after smaller meals. That physical sensation of fullness can be distinct from a reduction in the urge to eat, and both matter. If you are curious about what Wegovy's appetite suppression actually consists of, that distinction is worth exploring.

What affects how quickly the appetite change becomes noticeable

Several practical factors influence how early or clearly the appetite suppression registers, and some of them are within your control.

Eating patterns matter more than people expect. Semaglutide reduces appetite most clearly when meals are structured and not rushed. Eating quickly, past the point of fullness, can override the slower gastric signals the medicine is trying to create. Paying attention to what you eat on Wegovy is part of getting the most from the treatment, there is guidance on the foods that tend to work well alongside semaglutide, which is worth reading as you settle into the first weeks.

Hydration plays a role too. Dehydration can blur the distinction between thirst and hunger. People who drink well throughout the day often report the appetite signal is cleaner and more noticeable.

Sleep and stress are less obvious factors but real ones. Poor sleep elevates ghrelin (a hunger hormone) independently of what semaglutide is doing, which can mask or blunt the appetite-reducing effect.

Finally, injection timing is worth a brief mention. Semaglutide peaks in the bloodstream roughly one to three days after each weekly injection, so appetite may feel mildly stronger in the day or two before the next dose is due, that is pharmacology, not the medicine failing. Your prescriber can advise on the best day and time to inject if this pattern bothers you. Thinking about why Wegovy may not seem to be suppressing appetite in the expected way is something many people go through, and it is usually explainable.

If appetite suppression feels absent or has faded

We hear this question a lot: what if weeks pass and the hunger simply does not shift? There are a few possibilities worth raising with your prescriber. One is dose, at 0.25 mg or 0.5 mg, the absence of strong appetite suppression is normal and expected. Another is whether the medicine is being absorbed and used correctly (injection technique, site rotation, storage conditions all affect this). A third is whether something in diet or lifestyle is working against the effect.

If appetite suppression that was present has faded, that is a different picture. Some people describe a plateau in the appetite effect at a given dose after several months. Whether to increase the dose, maintain it, or review the approach is a clinical decision made with your prescriber, it is not something to adjust independently.

For a fuller look at what to do when Wegovy does not seem to suppress appetite at all, that page covers the clinical and practical considerations in more depth. And if you are weighing up whether this effect alone is what Wegovy does, the answer is no, appetite is part of a broader picture, explored in our page on whether Wegovy only suppresses appetite.

We know that waiting for a medicine to work when you have already waited a long time to access treatment is genuinely hard. That feeling is real, and it is worth naming. The timeline is slower than the headlines suggest, but for most people, it does shift.

If you are considering starting treatment or want to discuss where you are in your titration, speaking to our prescribers is a straightforward next step. The full picture of how Wegovy works, including eligibility and what to expect, is also on our treatment overview, or you can speak to our prescribers through a free consultation at any point.